Lan Coffman
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer (NCT05942300) | Lan Coffman | 2024-01-30 |
Track Lan Coffman automatically
Every clearance here is in the API, with alerts when new ones post.